Madhav Drugs Private Limited, a active private limited company, was established on 07 December 2004 in Na, Delhi, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24232DL2004PTC131016. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.70 M.
It upholds a compliant status. Its leadership includes Madhav Aggarwal (Director), Ashutosh Aggarwal (Additional Director), Sandhya (Director). Past directors included Anu Kumar, Hemant Kumar, Ashutosh Aggarwal. It holds ₹9.00 M open charges and ₹8.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D-2-C Ashoka Road Adarsh Nagardelhi-33, Na, Delhi.
U24232DL2004PTC131016
131016
07 December 2004
₹1.00 M
₹0.70 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Madhav Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhav Aggarwal | Director | 21 Dec 2015 | Current |
| Ashutosh Aggarwal | Additional Director | 14 Jun 2023 | Current |
| Sandhya | Director | 07 Dec 2004 | Current |
| Ashok Kumar Agarwal | Director | 07 Dec 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 22 Jan 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Madhav Drugs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.32% decrease. The company also saw a substantial fall in profitability, with a 205.58% decrease in profit. The company's net worth dipped by a decrease of 0.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Madhav Drugs had a public holding of 45.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹9,000,000.00
₹8,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 2023 | Canara Bank | ₹9.00 M | Open |
| 30 Jan 2014 | Syndicate Bank | ₹5.00 M | Satisfied |
| 23 Feb 2007 | Canara Bank | ₹1.00 M | Satisfied |
| 08 Dec 2005 | Canara Bank | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Madhav Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Madhav Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Madhav Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Madhav Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Madhav Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity A charge with Canara Bank amounted to Rs. 9.00 M with Charge ID 100755608 was registered on 24 Jul 2023. was completed.
Ashutosh Aggarwal was appointed as a Additional Director was appointed as a Additional Director on 14 Jun 2023 & has been associated with this company since 2 years 5 months . was recorded as a recent event.
Progress on A charge registered on 30 Jan 2014 via Charge ID 10477703 with Syndicate Bank was fully satisfied on 23 Aug 2022. was documented.
Progress on A charge registered on 23 Feb 2007 via Charge ID 10041392 with Canara Bank was fully satisfied on 23 Aug 2022. was documented.
The CIN of Madhav Drugs Private Limited is U24232DL2004PTC131016.
Madhav Drugs Private Limited is headquartered at D-2-C Ashoka Road Adarsh Nagardelhi-33, Na, Delhi.
Madhav Drugs Private Limited was incorporated on 07 December 2004.
The current directors of Madhav Drugs Private Limited are
The primary industry of Madhav Drugs Private Limited is Manufacturing.
Madhav Drugs Private Limited is unlisted.
The authorized capital of Madhav Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.70 M.
The compliance status of Madhav Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX